Indication
Prophylaxis of influenza caused by A (H1N1v) 2009 virus. Focetria should be used in accordance with official guidance.
Loading your page…
Loading your page…
Influenza, Human;Immunization;Disease Outbreaks
Marketing Authorisation Holder: Novartis Vaccines and Diagnostics S.r.l.
EMA Authorisation: 02/05/2007
INN: influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted)
AI Drug & Interaction Analysis
Free account required
Ask Osler about Focetria: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.